COMMUNIQUÉ DE PRESSE
par Marinomed Biotech AG
EQS-Adhoc: Marinomed Biotech AG: Court opens restructuring proceedings without self-administration
EQS-Ad-hoc: Marinomed Biotech AG / Key word(s): Insolvency/Restructure of Company
Marinomed Biotech AG: Court opens restructuring proceedings without self-administration
14-Aug-2024 / 15:35 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Korneuburg, Austria, 14. August 2024 – Marinomed Biotech AG (VSE:MARI) announces that on August 14, 2024, the Regional Court of Korneuburg opened restructuring proceedings without self-administration at the request of Marinomed Biotech AG. The Company expects trading of Marinomed shares to resume soon and a switch to the standard market continuous on the Vienna Stock Exchange.
+++ End of ad-hoc announcement +++
+++ End of ad-hoc announcement +++
End of Inside Information
14-Aug-2024 CET/CEST News transmitted by EQS Group AG. www.eqs.com
| Language: | English |
| Company: | Marinomed Biotech AG |
| Hovengasse 25 | |
| 2100 Korneuburg | |
| Austria | |
| Phone: | +43 2262 90300 |
| E-mail: | office@marinomed.com |
| Internet: | www.marinomed.com |
| ISIN: | ATMARINOMED6 |
| WKN: | A2N9MM |
| Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt, Munich, Stuttgart, Tradegate Exchange; Vienna Stock Exchange (Official Market) |
| EQS News ID: | 1968247 |
| End of Announcement | EQS News Service |
1968247 14-Aug-2024 CET/CEST